Literature DB >> 1711085

Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.

H Gascan1, J F Gauchat, G Aversa, P Van Vlasselaer, J E de Vries.   

Abstract

IL-4 induces IgE and IgG4 synthesis, but in addition to IL-4, a second signal provided by CD4+ T cells is required. Here we demonstrate that the signal provided by CD4+ T cells can be replaced by anti-CD40 mAb. Highly purified surface (sIgM+) human B cells cultured with soluble anti-CD40 mAb in the presence of IL-4 produced IgM, total IgG, IgG4, and relatively high levels of IgE, indicating that production of these isotypes represented H chain switching and was not the result of a selective outgrowth of isotype committed B cells. No IgA was produced in these cultures. However, the T cell signal was different from the signal provided by anti-CD40 mAb, because in contrast to CD4+ T cells, anti-CD40 mAb failed to induce germ-line epsilon transcripts. However, anti-CD40 mAb strongly enhanced germ-line epsilon mRNA expression induced by IL-4. In addition, IFN-gamma, IFN-alpha, and anti-CD23 mAb, which block IL-4-induced IgE production by PBMC, or B cells cocultured with CD4+ T cell clones, failed to inhibit IgG4 and IgE synthesis induced by anti-CD40 mAb. Finally, anti-CD40 mAb and CD4+ T cell clones had strong synergistic effects on IgG4 and IgE synthesis. These results indicate that different B cell activation pathways can result in IgG4 and IgE switching in the presence of IL-4.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711085

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

Authors:  R J Noelle; M Roy; D M Shepherd; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

2.  Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.

Authors:  N R Ling; B Brown; D Hardie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 3.  The biology of the human ligand for CD40.

Authors:  M K Spriggs; W C Fanslow; R J Armitage; J Belmont
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

4.  In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells.

Authors:  B A de Boer; Y C Kruize; M Yazdanbakhsh
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

Review 5.  Cross-linking reconsidered: binding and cross-linking fields and the cellular response.

Authors:  B Sulzer; R J De Boer; A S Perelson
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

6.  Class switch recombination in selective IgA-deficient subjects.

Authors:  L Hummelshoj; L P Ryder; L K Nielsen; C H Nielsen; L K Poulsen
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

7.  T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand.

Authors:  P Life; J F Gauchat; V Schnuriger; S Estoppey; G Mazzei; A Durandy; A Fischer; J Y Bonnefoy
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

8.  Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.

Authors:  K Agematsu; H Nagumo; K Shinozaki; S Hokibara; K Yasui; K Terada; N Kawamura; T Toba; S Nonoyama; H D Ochs; A Komiyama
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Purified excretory-secretory component of filarial parasite enhances Fc epsilon RII/CD23 expression on human splenic B and T cells and IgE synthesis while potentiating T-helper type 2-related cytokine generation from T cells.

Authors:  K A Yamaoka; J P Kolb; N Miyasaka; G Inuo; K Fujita
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.

Authors:  Kevin N Heller; Frida Arrey; Peter Steinherz; Carol Portlock; Amy Chadburn; Kara Kelly; Christian Münz
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.